HIV-1 Resistance Outcomes in Seroconverters from MTN 003 (VOICE)
Background: The emergence of drug resistance is a major concern when using antiretroviral agents for HIV prevention. Of six HIV prevention trials that included tenofovir (TFV)-based study products, only 3 cases of resistance have been reported in 155 participants who acquired HIV after enrollment and seroconverted on product. We evaluated seroconverters in MTN 003 (VOICE)…